Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 19 studies | 34% ± 13% | |
mesothelial cell | 7 studies | 37% ± 10% | |
fibroblast | 4 studies | 29% ± 9% | |
oligodendrocyte precursor cell | 3 studies | 31% ± 17% | |
glutamatergic neuron | 3 studies | 26% ± 7% | |
GABAergic neuron | 3 studies | 26% ± 3% |
Insufficient scRNA-seq data for expression of SEMA3D at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 96% | 631.79 | 235 / 245 | 80% | 6.15 | 401 / 502 |
lung | 97% | 654.04 | 561 / 578 | 59% | 2.80 | 683 / 1155 |
thymus | 100% | 3284.95 | 651 / 653 | 49% | 11.44 | 299 / 605 |
breast | 88% | 547.42 | 406 / 459 | 55% | 2.13 | 614 / 1118 |
bladder | 86% | 559.71 | 18 / 21 | 39% | 2.06 | 195 / 504 |
brain | 46% | 133.25 | 1209 / 2642 | 73% | 5.86 | 518 / 705 |
skin | 61% | 204.64 | 1112 / 1809 | 56% | 7.34 | 263 / 472 |
ovary | 71% | 272.39 | 127 / 180 | 45% | 1.60 | 194 / 430 |
kidney | 62% | 197.78 | 55 / 89 | 44% | 3.27 | 400 / 901 |
uterus | 71% | 200.63 | 120 / 170 | 30% | 1.87 | 138 / 459 |
spleen | 100% | 4270.20 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.51 | 1 / 1 |
adrenal gland | 89% | 333.16 | 230 / 258 | 8% | 0.41 | 18 / 230 |
blood vessel | 95% | 1046.01 | 1274 / 1335 | 0% | 0 | 0 / 0 |
intestine | 72% | 245.70 | 691 / 966 | 17% | 0.61 | 87 / 527 |
adipose | 88% | 643.15 | 1059 / 1204 | 0% | 0 | 0 / 0 |
stomach | 63% | 150.34 | 227 / 359 | 24% | 1.03 | 68 / 286 |
esophagus | 31% | 117.90 | 449 / 1445 | 50% | 4.60 | 91 / 183 |
tonsil | 0% | 0 | 0 / 0 | 42% | 1.65 | 19 / 45 |
pancreas | 1% | 3.21 | 4 / 328 | 39% | 0.99 | 69 / 178 |
heart | 33% | 93.81 | 282 / 861 | 0% | 0 | 0 / 0 |
liver | 8% | 15.66 | 19 / 226 | 10% | 0.39 | 42 / 406 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.35 | 5 / 29 |
peripheral blood | 1% | 1.34 | 7 / 929 | 0% | 0 | 0 / 0 |
muscle | 1% | 1.80 | 6 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071526 | Biological process | semaphorin-plexin signaling pathway |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0001755 | Biological process | neural crest cell migration |
GO_0007411 | Biological process | axon guidance |
GO_0050919 | Biological process | negative chemotaxis |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0045499 | Molecular function | chemorepellent activity |
GO_0030215 | Molecular function | semaphorin receptor binding |
Gene name | SEMA3D |
Protein name | Semaphorin 3D Semaphorin-3D |
Synonyms | UNQ760/PRO1491 |
Description | FUNCTION: Induces the collapse and paralysis of neuronal growth cones. Could potentially act as repulsive cues toward specific neuronal populations. Binds to neuropilin (By similarity). . |
Accessions | C9JYT6 ENST00000444867.1 O95025 ENST00000284136.11 |